paclitaxel has been researched along with Sarcoma, Epithelioid in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 25 (39.06) | 18.2507 |
2000's | 21 (32.81) | 29.6817 |
2010's | 13 (20.31) | 24.3611 |
2020's | 5 (7.81) | 2.80 |
Authors | Studies |
---|---|
Fairchild, C; Johnston, K; Kadow, JF; Lee, FL; Long, BH; Rose, WC; Vyas, DM; Wittman, MD | 1 |
Choi, Y; Jin, Y; Jung, HY; Kaur, N; Kim, DK; Kim, EK; Kim, ES; Lee, K; Min, KH; Min, YK; Park, MK; Xia, Y | 1 |
Agar, N; Blessing, WA; Colby, AH; Colson, YL; Digesu, CS; Grinstaff, MW; Hachey, KJ; Korunes-Miller, JT; Kumar, A; Liu, R; Mahvi, DA; Raut, CP; Regan, MS; Shih, A; Tal-Mason, A | 1 |
Bay, JO; El-Ghazzi, N | 1 |
Berry, S; Bordeianu, C; Chu, NQ; Colson, YL; Geller, AD; Grinstaff, MW; Hung, YP; Korunes-Miller, J; Mahvi, DA; Raut, CP; Sabatelle, R | 1 |
Li, P; Tian, Z; Wang, J; Wang, X; Yang, J; Yao, W; Zhang, F; Zhang, P | 1 |
Akazawa, T; Honma, K; Inoue, T; Kawachi, H; Kawamura, T; Kuhara, H; Kukita, Y; Kumagai, T; Kunimasa, K; Mizote, Y; Nakamura, H; Nishino, K; Tahara, H; Tamiya, M | 1 |
Blaydorn, L; Coats, J; Farley, JH; Khemka, V; Lynch, CA; McGahey, K; Niu, J; Sangal, A; Waypa, J; Weiss, GJ | 1 |
Alazraki, AL; Amankwah, EK; Cash, T; Clark, D; George, BA; Metts, JL; Olson, TA; Wasilewski-Masker, KJ | 1 |
Chawla, SP; Dry, SM; Eilber, FC; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kawaguchi, K; Kimura, H; Li, Y; Miwa, S; Miyake, K; Nelson, SD; Oshiro, H; Razmjooei, S; Singh, SR; Tsuchiya, H; Wangsiricharoen, S; Yamamoto, N; Zhang, Z | 1 |
Chin, F; Farid, M; Ho, ZC; Jeevan, R; Lee, MJ; Ong, WS; Poon, D; Quek, R; Sairi, AN; Soh, LT; Teh, J; Teo, M | 1 |
Antoine, M; Bonnette, P; Cadranel, J; Cazes, A; Duruisseaux, M; Girard, N; Mazieres, J; Monnet, I; Ung, M; Vieira, T; Wislez, M | 1 |
Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY | 1 |
Franciosi, AI; Guérios, SD; Pezzini, PC; Silva, DM | 1 |
Bao, Y; Chu, Q; Tan, S; Wu, T; Wu, Y; Zhang, Z; Zhuang, X | 1 |
Ajgal, Z; Alexandre, J; Boudou-Rouquette, P; Cessot, A; Chapuis, N; Emile, G; Fontenay, M; Goldwasser, F; Huillard, O; Tigaud, JM | 1 |
Akkar, OB; Karadayi, K; Karakus, S; Kurt, A; Ugurlu, GP; Yanik, A; Yildiz, C | 1 |
Ahn, KS; Jeong, SJ; Jung, MH; Kim, SH; Lee, EO; Lee, HJ; Lee, SY; Rhee, YH | 1 |
Ito, T; Kawashima, H; Nakatani, T; Omachi, T; Tamada, S | 1 |
Movva, S; Verschraegen, C | 1 |
Baranzelli, MC; Barnouin, L; Bay, JO; Bui, NB; Chevreau, C; Cupissol, D; Eymard, JC; Lortholary, A; Mita, M; Pivot, X; Savary, J; Thyss, A | 1 |
Bertino, JR; Li, W | 1 |
Alvarez, RD; Kim, RY; Omura, GA | 1 |
Arai, Y; Endo, M; Hagisawa, S; Hiramatu, M; Hoshi, S; Ohyama, C; Satoh, M; Watanabe, R | 1 |
Brodowicz, T; Grunt, T; Halaschek, J; Haller, G; Horak, P; Koestler, W; Krainer, M; Pribill, I; Tomek, S; Wiltschke, C; Zielinski, CC | 1 |
Aravantinos, G; Bafaloukos, D; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, C; Kosmidis, P; Linardou, H; Papadimitriou, C; Papakostas, P; Skarlos, D | 1 |
Katakami, N; Nakahira, A; Ogino, H; Sasaki, H | 1 |
Gabbert, HE; Grinstein, E; Haremza, J; Heikaus, S; Mahotka, C; Matuszek, KS; Ramp, U; Reinecke, P; Suschek, CV | 1 |
Aamdal, S; Catimel, G; Sternberg, C; Sulkes, A; van Hoesel, Q; Verweij, J; Wolff, I | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC | 1 |
Catimel, G; Clavel, M; Kerbrat, P; Kerger, J; Tursz, T; van Glabbeke, M; van Hoesel, QG; van Oosterom, AT; van Pottelsberghe, C; Verweij, J | 1 |
Cheson, BD | 1 |
Goodin, S; Gosland, M; Hoffman, T; Tsuboi, C; Vore, M | 1 |
Aziz, SM; Crooks, PA; Gillespie, MN; Gosland, MP; Olson, JW; Tofiq, S; Tsuboi, CP | 1 |
Balcerzak, SP; Benedetti, J; Natale, RB; Weiss, GR | 1 |
Beketic-Oreskovic, L; Dumontet, C; Duran, GE; Sikic, BI; Steger, KA | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L | 1 |
Verweij, J | 1 |
Ebbert, LP; Edmonson, JH; Gerstner, JB; Jung, SH; McGaw, H; Nascimento, AG | 1 |
Colvin, OM | 1 |
Valero, V | 1 |
Skubitz, KM | 1 |
Gian, VG; Johnson, TJ; Lynch, JW; Marsh, RW; Schuhmacher, C | 1 |
Chahinian, AP; Gluck, H; Holland, JF; Mandeli, JP; Naim, H; Teirstein, AS | 1 |
Bodin, F; Dumontet, C; Michal, Y | 1 |
Fox, S; Meyers, T; Rougraff, B; Sandler, A | 1 |
Bertino, JR; Casper, ES; Ilson, D; Leung, D; Pfister, D; Schwartz, GK; Sugarman, A; Waltzman, RJ; Woodruff, J | 1 |
Blaschke, TF; Duran, GE; Man, MC; Sikic, BI; Washington, CB | 1 |
Budman, DR; Calabro, A; Kreis, W | 1 |
Orel, NF | 1 |
Burger, RA; Chen, L; Cheng, H; Khan, SA; Lincoln, AJ; Mallarino, MC; Monk, BJ; Zaunbrecher, GM | 1 |
Bohling, CA; Forrest, LJ; Hershey, AE; Imondi, AR; Kurzman, ID; Placke, ME; Stonerook, M; Vail, DM | 1 |
Brodowicz, T; Köstler, WJ; Wiltschke, C; Zielinski, CC | 1 |
Gabbert, HE; Gerharz, CD; Knopf, C; Reinecke, P; Schmitz, M; Schneider, EM | 1 |
Baker, LH; Bruno, R; Hirth, J; Schott, A; Strawderman, M; Watkins, PB | 1 |
Buesa, J; Coleman, R; di Paola, ED; Judson, IR; Lee, SM; Ruka, W; Seynaeve, C; Tonelli, D; van Glabbeke, M; van Hoessel, R; Verweij, J | 1 |
Beketic-Oreskovic, L; Chen, GK; Durán, GE; Mangili, A; Sikic, BI | 1 |
Adams, LM; Budman, DR; Calabro, A; Kreis, W; Liu, XM; Stiel, L; Wang, LG | 1 |
Borzilleri, R; Fairchild, CR; Kim, SH; Kramer, RA; Lee, FY; Long, BH; Reventos-Suarez, C; Rose, WC; Vite, GD | 1 |
Fujikawa-Yamamoto, K; Ikeda, T; Murano, H; Ohdoi, C; Wang, S; Yamagishi, H | 1 |
Banerjee, D; Bertino, JR; Li, WW; Scotto, KW; Takahashi, N | 1 |
Amann, G; Attems, Y; Brodowicz, T; Fiebiger, WC; Hejna, M; Köstler, WJ; Krainer, M; Tomek, S; Wiltschke, CH; Zielinski, CC | 1 |
Brandl, M; Burger, AM; Fiebig, HH; Massing, U; Moog, R; Schubert, R; Schüler, J; Unger, C | 1 |
Banerji, N; Kanjilal, S; Kapur, V; Klausner, JS; Li, X | 1 |
5 review(s) available for paclitaxel and Sarcoma, Epithelioid
Article | Year |
---|---|
Systemic management strategies for metastatic soft tissue sarcoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dioxoles; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Lysine; Paclitaxel; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin | 2011 |
Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Female; Humans; Multicenter Studies as Topic; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Sarcoma; Uterine Neoplasms | 2002 |
Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carboplatin; Carcinoma, Renal Cell; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gemcitabine; Humans; Immunohistochemistry; Kidney Neoplasms; Neoplasm Staging; Nephrectomy; Paclitaxel; Sarcoma; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Drug resistance in the treatment of sarcomas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Paclitaxel; Platinum Compounds; Sarcoma | 1997 |
[Taxotere in various solid tumors].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Taxoids; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1998 |
15 trial(s) available for paclitaxel and Sarcoma, Epithelioid
Article | Year |
---|---|
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
Topics: Adenocarcinoma; Adult; Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diarrhea; Docetaxel; Doxorubicin; Drug Eruptions; Fatigue; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Polyethylene Glycols; Sarcoma; Small Cell Lung Carcinoma; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting | 2017 |
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Sarcoma; Survival Analysis | 2002 |
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Female; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Liposomes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Safety; Sarcoma; Survival Rate; Time Factors; Treatment Outcome | 2004 |
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Head and Neck Neoplasms; Humans; Melanoma; Middle Aged; Neoplasms; Paclitaxel; Sarcoma; Stomach Neoplasms; Taxoids | 1995 |
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma | 1995 |
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Europe; Female; Humans; Leukopenia; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Taxoids; Thrombocytopenia | 1994 |
A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Prospective Studies; Remission Induction; Sarcoma; Thrombocytopenia | 1995 |
Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Sarcoma; Taxoids | 1995 |
Phase II study of docetaxel in advanced soft tissue sarcomas.
Topics: Adult; Aged; Alopecia; Anorexia; Antiemetics; Antineoplastic Agents, Phytogenic; Cause of Death; Dexamethasone; Diarrhea; Diphenhydramine; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Leukopenia; Male; Middle Aged; Nausea; Paclitaxel; Patient Selection; Premedication; Remission Induction; Sarcoma; Taxoids; Uterine Neoplasms; Vomiting | 1996 |
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclophosphamide; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Premedication; Remission Induction; Sarcoma; Taxoids | 1997 |
Paclitaxel (Taxol) plus doxorubicin plus filgrastim in advanced sarcoma: a phase II study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leiomyosarcoma; Male; Middle Aged; Paclitaxel; Recombinant Proteins; Sarcoma; Survival Rate | 1998 |
Phase II trial of paclitaxel in patients with soft-tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Sarcoma | 1998 |
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.
Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Erythromycin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Orosomucoid; Paclitaxel; Sarcoma; Soft Tissue Neoplasms; Taxoids | 2000 |
Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and b
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cross-Over Studies; Disease Progression; Docetaxel; Doxorubicin; Female; Humans; Male; Paclitaxel; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Taxoids; Treatment Outcome | 2000 |
Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Sarcoma; Soft Tissue Neoplasms; Taxoids; Treatment Outcome | 2001 |
44 other study(ies) available for paclitaxel and Sarcoma, Epithelioid
Article | Year |
---|---|
Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Chlorambucil; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives.
Topics: Adamantane; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Sarcoma; Structure-Activity Relationship | 2009 |
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Humans; Mice; Neoplasm Recurrence, Local; Paclitaxel; Sarcoma | 2022 |
[Rare tumors: Angiosarcoma].
Topics: Breast Neoplasms; Female; Hemangiosarcoma; Humans; Paclitaxel; Prognosis; Sarcoma | 2023 |
High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Mice; Paclitaxel; Polymers; Sarcoma | 2023 |
Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma.
Topics: Adult; Albumin-Bound Paclitaxel; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Progression-Free Survival; Retrospective Studies; Sarcoma; Treatment Outcome | 2020 |
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Bevacizumab; Carboplatin; DNA Helicases; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Paclitaxel; Sarcoma; Transcription Factors; Treatment Outcome | 2021 |
Gemcitabine/nab-paclitaxel for pediatric relapsed/refractory sarcomas.
Topics: Adolescent; Albumins; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Gemcitabine; Hematologic Diseases; Humans; Infections; Kaplan-Meier Estimate; Male; Paclitaxel; Recurrence; Salvage Therapy; Sarcoma; Young Adult | 2018 |
The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Topics: Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Models, Animal; Female; Gemcitabine; Humans; Mice; Mice, Nude; Middle Aged; Paclitaxel; Sarcoma; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Male; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Scalp; Singapore; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2013 |
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gemcitabine; Giant Cell Tumors; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Quinazolines; Retrospective Studies; Sarcoma; Survival Rate; Taxoids; Vinblastine; Vinorelbine | 2013 |
Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Young Adult | 2013 |
Subcutaneous administration of paclitaxel in dogs with cancer: A preliminary study.
Topics: Animals; Carcinoma; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Lymphoma; Male; Mastocytoma; Paclitaxel; Sarcoma | 2015 |
D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Micelles; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sarcoma; Succinates; Vitamin E | 2015 |
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Case-Control Studies; Doxorubicin; Female; Hand-Foot Syndrome; Hematologic Diseases; Humans; Leukocyte Count; Male; Middle Aged; Monocytes; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Polyethylene Glycols; Retrospective Studies; Sarcoma; Stomatitis; Thymus Neoplasms; Young Adult | 2015 |
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for gynecological malignancies: a single center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cohort Studies; Cytoreduction Surgical Procedures; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Sarcoma; Survival Rate; Treatment Outcome; Uterine Neoplasms; Young Adult | 2016 |
Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cinchona Alkaloids; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Paclitaxel; Quinidine; Sarcoma; Uterine Neoplasms | 2011 |
[Primary urothelial carcinoma with sarcomatous transformation of the prostate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Urethral Neoplasms | 2010 |
Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Caspase 9; Caspases; Cell Cycle; Cell Death; Cell Separation; Chalcone; Chalcones; Cytochrome c Group; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; fas Receptor; Flow Cytometry; Humans; Imidazoles; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Sarcoma; Signal Transduction; Soft Tissue Neoplasms; Time Factors; Tumor Cells, Cultured | 2002 |
Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; DNA Fragmentation; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Humans; Immunohistochemistry; Membrane Glycoproteins; Paclitaxel; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma; Soft Tissue Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2003 |
Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Chemotherapy, Adjuvant; Humans; Male; Paclitaxel; Pulmonary Artery; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Vascular Neoplasms | 2007 |
Paclitaxel (Taxol)-induced apoptosis in human epithelioid sarcoma cell lines is enhanced by upregulation of CD95 ligand (FasL/Apo-1L).
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Paclitaxel; RNA, Messenger; Sarcoma; Signal Transduction; Up-Regulation | 2008 |
Clinical trials referral resource. Update on taxol trials.
Topics: Acute Disease; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Sarcoma | 1993 |
17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
Topics: Cholestasis; Doxorubicin; Drug Resistance; Estradiol; Estriol; Etoposide; Humans; Leukemia, Myeloid; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vinblastine | 1993 |
Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
Topics: Antineoplastic Agents; Doxorubicin; Drug Resistance, Multiple; Etoposide; Guanidines; Humans; Paclitaxel; Polymers; Sarcoma; Spermine; Tumor Cells, Cultured; Vinblastine | 1996 |
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Drug Resistance; Female; Humans; Molecular Sequence Data; Mutation; Paclitaxel; Sarcoma; Tubulin; Tumor Cells, Cultured; Uterine Neoplasms | 1996 |
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia | 1996 |
A phase I study of ambulatory continuous infusion paclitaxel.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Agents, Phytogenic; Clinical Trials, Phase I as Topic; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Sarcoma; Soft Tissue Neoplasms | 1997 |
A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue sarcomas or bone sarcomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Clinical Trials, Phase II as Topic; Female; Humans; Male; Middle Aged; Paclitaxel; Recurrence; Sarcoma; Soft Tissue Neoplasms | 1996 |
Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fibrosarcoma; Humans; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Pleural Neoplasms; Sarcoma; Suramin; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance.
Topics: Antineoplastic Agents, Phytogenic; Biological Transport; Cell Division; Cell Survival; Docetaxel; Drug Resistance, Multiple; Humans; Hyperthermia, Induced; Leukemia, Erythroblastic, Acute; Paclitaxel; Sarcoma; Taxoids; Temperature; Tumor Cells, Cultured; Vinblastine | 1998 |
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
Topics: Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HIV Protease Inhibitors; Humans; Indinavir; Leukemia, Erythroblastic, Acute; Nelfinavir; Paclitaxel; Ritonavir; Saquinavir; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms; Vinblastine | 1998 |
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gemcitabine; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 1998 |
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitro.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Isoenzymes; Paclitaxel; Protein Kinase C; Sarcoma; Signal Transduction; Tumor Cells, Cultured; Uterine Neoplasms | 1999 |
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Dog Diseases; Dogs; Doxorubicin; Female; Lung Neoplasms; Male; Melanoma; Paclitaxel; Sarcoma | 1999 |
Efficacy of docetaxel in the second-line treatment of locally advanced or metastatic soft tissue sarcoma after failure of chemotherapy with anthracycline or ifosfamide.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Paclitaxel; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Taxoids | 1999 |
Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Differentiation; Cell Division; Drug Resistance, Multiple; Flow Cytometry; Humans; Micronuclei, Chromosome-Defective; Microscopy, Electron; Microtubules; Multidrug Resistance-Associated Proteins; Paclitaxel; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Time Factors; Tumor Cells, Cultured | 2000 |
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Paclitaxel; Phenotype; Rhodamine 123; RNA, Messenger; Sarcoma; Tritium; Tumor Cells, Cultured; Uterine Neoplasms; Vault Ribonucleoprotein Particles; Vinblastine | 2000 |
Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Survival; Colonic Neoplasms; Disease Models, Animal; Drug Resistance, Neoplasm; Epothilones; Epoxy Compounds; Female; Humans; Infusions, Parenteral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Sarcoma; Thiazoles; Tubulin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2001 |
Establishment of a tetraploid Meth-A cell line through polyploidization by demecolcine but not by staurosporine, K-252A and paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbazoles; Cell Count; Cell Cycle; Cell Division; Demecolcine; DNA; Enzyme Inhibitors; Flow Cytometry; Indole Alkaloids; Karyotyping; Mice; Paclitaxel; Ploidies; Sarcoma; Staurosporine; Tumor Cells, Cultured | 2001 |
Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Dioxoles; Doxorubicin; Drug Synergism; Flow Cytometry; Humans; Inhibitory Concentration 50; Isoquinolines; Microscopy, Fluorescence; Paclitaxel; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Trimetrexate; Tumor Cells, Cultured | 2001 |
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Deoxycytidine; Docetaxel; Gels; Gemcitabine; Half-Life; Humans; Liposomes; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Phospholipids; Sarcoma; Taxoids; Tissue Distribution; Transplantation, Heterologous; Urinary Bladder Neoplasms; Vindesine | 2002 |
Evaluation of in vitro chemosensitivity of vaccine-associated feline sarcoma cell lines to vincristine and paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cat Diseases; Cats; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Inhibitory Concentration 50; Male; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vaccination; Vincristine | 2002 |